12:00 AM
Apr 23, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Wittycell S.A.S.

Paris, France

Technology: Adjuvants for prophylactic and therapeutic vaccines based on natural killer T cell stimulation

Disease focus:...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >